Inspire Medical Systems Net Profit Margin 2017-2024 | INSP
Current and historical net profit margin for Inspire Medical Systems (INSP) from 2017 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue. Inspire Medical Systems net profit margin for the three months ending September 30, 2024 was .
| Inspire Medical Systems Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-09-30 | $0.76B | $0.03B | 4.37% |
| 2024-06-30 | $0.71B | $0.01B | 0.85% |
| 2024-03-31 | $0.66B | $-0.02B | -2.42% |
| 2023-12-31 | $0.63B | $-0.02B | -3.36% |
| 2023-09-30 | $0.57B | $-0.03B | -5.79% |
| 2023-06-30 | $0.53B | $-0.04B | -7.79% |
| 2023-03-31 | $0.47B | $-0.04B | -9.23% |
| 2022-12-31 | $0.41B | $-0.05B | -11.06% |
| 2022-09-30 | $0.35B | $-0.05B | -14.41% |
| 2022-06-30 | $0.30B | $-0.04B | -14.33% |
| 2022-03-31 | $0.26B | $-0.04B | -16.03% |
| 2021-12-31 | $0.23B | $-0.04B | -17.60% |
| 2021-09-30 | $0.20B | $-0.05B | -22.89% |
| 2021-06-30 | $0.18B | $-0.05B | -26.29% |
| 2021-03-31 | $0.13B | $-0.06B | -41.79% |
| 2020-12-31 | $0.12B | $-0.06B | -48.70% |
| 2020-09-30 | $0.10B | $-0.06B | -60.42% |
| 2020-06-30 | $0.08B | $-0.06B | -69.14% |
| 2020-03-31 | $0.09B | $-0.04B | -47.13% |
| 2019-12-31 | $0.08B | $-0.03B | -40.24% |
| 2019-09-30 | $0.07B | $-0.03B | -40.28% |
| 2019-06-30 | $0.06B | $-0.03B | -40.63% |
| 2019-03-31 | $0.06B | $-0.02B | -42.11% |
| 2018-12-31 | $0.05B | $-0.02B | -45.10% |
| 2018-09-30 | $0.04B | $-0.02B | -50.00% |
| 2018-06-30 | $0.04B | $-0.02B | -55.26% |
| 2018-03-31 | $0.03B | $-0.02B | -60.61% |
| 2017-12-31 | $0.03B | $-0.02B | -60.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.669B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hims & Hers Health (HIMS) | United States | $5.506B | 140.00 |
| Tempus AI (TEM) | United States | $5.393B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.799B | 0.00 |
| Enovis (ENOV) | United States | $2.475B | 16.78 |
| Privia Health (PRVA) | United States | $2.357B | 196.40 |
| Azenta (AZTA) | United States | $2.286B | 122.05 |
| Omnicell (OMCL) | United States | $2.053B | 67.15 |
| 10x Genomics (TXG) | United States | $1.718B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.568B | 0.00 |
| Schrodinger (SDGR) | United States | $1.486B | 0.00 |
| Phreesia (PHR) | United States | $1.464B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.846B | 0.00 |
| Standard BioTools (LAB) | United States | $0.651B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.563B | 0.00 |
| Talkspace (TALK) | United States | $0.529B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.476B | 82.40 |
| Health Catalyst (HCAT) | United States | $0.446B | 0.00 |
| TruBridge (TBRG) | United States | $0.297B | 86.52 |
| Pulmonx (LUNG) | United States | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.114B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.090B | 0.00 |
| HeartBeam (BEAT) | United States | $0.063B | 0.00 |
| CareCloud (CCLD) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.061B | 0.00 |
| 111 (YI) | China | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.041B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.018B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.008B | 0.00 |
| Precipio (PRPO) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |